Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vicarious Surgical (RBOT)
NYSE:RBOT
Vicarious Surgical (RBOT) Stock Price & Analysis
181 Followers
RBOT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.19 - $62.10
Previous Close$8.63
Volume33.30K
Average Volume (3M)34.17K
Market Cap
$50.74M
Enterprise Value-$18.80M
Total Cash (Recent Filing)$84.13M
Total Debt (Recent Filing)$14.59M
Price to Earnings (P/E)―
Beta2.59
Next Earnings
Aug 05, 2024EPS Estimate
-$2.79Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.39
Shares Outstanding5,879,415
10 Day Avg. Volume41,513
30 Day Avg. Volume34,166
Standard Deviation0.20
R-Squared0.09
Alpha-0.07
Financial Highlights & Ratios
Price to Book (P/B)0.42
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda1.44
Forecast
1Y Price Target
$4.17Price Target Upside-52.07% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Vicarious Surgical News
PremiumCompany Announcements
Vicarious Surgical Announces Reverse Stock Split and Equity Plan Amendment
Bulls Say, Bears Say
Bulls Say
Financial StrategyRBOT's effective financial management is demonstrated by its spending optimization and cash burn rate, which is in line with previous guidance, indicating the company's commitment to financial stability.
Product DevelopmentRBOT has completed cadaveric testing for its V1.0 robotic system, a significant step towards refining and fully integrating advanced technology that promises enhanced maneuverability and 360-degree visualization.
Regulatory ProgressRBOT is including clinical data from international patients in its regulatory submissions, potentially expediting the enrollment process for initial clinical trials and supporting its strategy for De Novo submission.
Bears Say
Earnings ReportRBOT reported zero revenue and an adjusted loss per share as cash burn was tightened in the last quarter.
Financial PerformanceRBOT expects full-year cash burn to be roughly $50M, which is significant but considered necessary to reach key development milestones.
Stock RecommendationGiven the delays to product development and a tough macroeconomic environment, analysts recommend a neutral stance on the stock.
---
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
RBOT FAQ
What was Vicarious Surgical’s price range in the past 12 months?
Vicarious Surgical lowest stock price was $5.19 and its highest was $62.10 in the past 12 months.
What is Vicarious Surgical’s market cap?
Currently, no data Available
When is Vicarious Surgical’s upcoming earnings report date?
Vicarious Surgical’s upcoming earnings report date is Aug 05, 2024 which is in 20 days.
How were Vicarious Surgical’s earnings last quarter?
Vicarious Surgical released its earnings results on Apr 29, 2024. The company reported -$2.7 earnings per share for the quarter, beating the consensus estimate of -$2.85 by $0.15.
Is Vicarious Surgical overvalued?
According to Wall Street analysts Vicarious Surgical’s price is currently Overvalued.
Does Vicarious Surgical pay dividends?
Vicarious Surgical does not currently pay dividends.
What is Vicarious Surgical’s EPS estimate?
Vicarious Surgical’s EPS estimate is -$2.79.
How many shares outstanding does Vicarious Surgical have?
Vicarious Surgical has 5,225,423 shares outstanding.
What happened to Vicarious Surgical’s price movement after its last earnings report?
Vicarious Surgical reported an EPS of -$2.7 in its last earnings report, beating expectations of -$2.85. Following the earnings report the stock price went up 0.238%.
Which hedge fund is a major shareholder of Vicarious Surgical?
Among the largest hedge funds holding Vicarious Surgical’s share is Aristeia Capital LLC. It holds Vicarious Surgical’s shares valued at N/A.
---
Vicarious Surgical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.17 (-52.07% Downside)
$4.17 (-52.07% Downside)
Hedge Fund Trend
Decreased
By 1.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $30.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.1%
Last 30 Days ▲ 4.2%
Last 30 Days ▲ 4.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-84.19%
12-Months-Change
Fundamentals
Return on Equity
-71.21%
Trailing 12-Months
Asset Growth
-13.05%
Trailing 12-Months
Company Description
Vicarious Surgical
D8 Holdings Corp is a blank check company.
---
RBOT Earnings Call
Q1 2024
0:00 / 0:00
---
RBOT Stock 12 Month Forecast
Average Price Target
$4.17
▼(-52.07% Downside)
Technical Analysis
Best Analysts Covering RBOT
1 Year
1 Year Success Rate
2/4 ratings generated profit
1 Year Average Return
-14.35%
reiterated a buy rating 3 months ago
Copying Josh Jennings's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -14.35% per trade.
---